Search

Your search keyword '"Covello, Giuseppe"' showing total 17 results
Start Over Author "Covello, Giuseppe"
17 results on '"Covello, Giuseppe"'

1. Effectiveness and safety of XEN45 implant over 12 months of follow-up: data from the XEN-Glaucoma Treatment Registry

Author

Oddone, Francesco, Roberti, Gloria, Giammaria, Sara, Posarelli, Chiara, Ghirelli, Giorgio, Mastropasqua, Leonardo, Agnifili, Luca, Micelli Ferrari, Tommaso, Pace, Vincenzo, Nucci, Paolo, Sacchi, Matteo, Monsellato, Gianluca, Altafini, Romeo, Scuderi, Gianluca, Perdicchi, Andrea, Uva, Maurizio, Carnevale, Carmela, Covello, Giuseppe, Maglionico, Maria Novella, Fea, Antonio, and Figus, Michele

Published
2024
Full Text
View/download PDF

4. Evaluation of Anatomical and Tomographic Biomarkers as Predictive Visual Acuity Factors in Eyes with Retinal Vein Occlusion Treated with Dexamethasone Implant.

Author

Covello, Giuseppe, Maglionico, Maria Novella, Figus, Michele, Busoni, Chiara, Sartini, Maria Sole, Lupidi, Marco, and Posarelli, Chiara

Subjects
*RETINAL vein occlusion, *VISUAL acuity, *MACULAR edema, *BIOMARKERS, *REGRESSION analysis
Abstract

Background: This prospective study evaluated the impact of anatomical and tomographic biomarkers on clinical outcomes of intravitreal dexamethasone implants in patients with macular edema secondary to retinal vein occlusion (RVO). Methods: The study included 46 patients (28 with branch RVO (BRVO) and 18 with central RVO (CRVO)). Best corrected visual acuity (BCVA) significantly improved from a mean baseline of 0.817 ± 0.220 logMAR to 0.663 ± 0.267 logMAR at six months and 0.639 ± 0.321 logMAR at twelve months (p < 0.05). Central retinal thickness (CRT) showed a significant reduction from 666.2 ± 212.2 µm to 471.1 ± 215.6 µm at six months and 467 ± 175.7 µm at twelve months (p < 0.05). No significant differences were found in OCT biomarkers between baseline and follow-ups. Results: The study analysed improvements in visual acuity relative to baseline biomarkers. At six months, ellipsoid zone disruption (EZD) was significant for all subgroups. Disorganization of retinal inner layers (DRIL), external limiting membrane (ELM) disruption, macular ischemia (MI), CRT, and BRVO showed significance for any improvement, while DRIL and ELM were significant for changes greater than 0.3 logMAR (p < 0.05). At twelve months, EZD remained significant for all subgroups. ELM, MI, CRT, and BRVO were significant for any improvement, while MI and BRVO were significant for changes greater than 0.3 logMAR (p < 0.05). Hyperreflective foci were not statistically significant at either time point (p > 0.05). Conclusions: The regression model suggested that MI and CRVO could be negative predictive factors for visual outcomes, while ELM and EZD were associated with BCVA improvement one-year post-treatment. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

7. Effectiveness and safety of XEN45 implant over 12 months of follow-up: data from the XEN-Glaucoma Treatment Registry

Author

Oddone, Francesco, primary, Roberti, Gloria, additional, Giammaria, Sara, additional, Posarelli, Chiara, additional, Ghirelli, Giorgio, additional, Mastropasqua, Leonardo, additional, Agnifili, Luca, additional, Micelli Ferrari, Tommaso, additional, Pace, Vincenzo, additional, Nucci, Paolo, additional, Sacchi, Matteo, additional, Monsellato, Gianluca, additional, Altafini, Romeo, additional, Scuderi, Gianluca, additional, Perdicchi, Andrea, additional, Uva, Maurizio, additional, Carnevale, Carmela, additional, Covello, Giuseppe, additional, Maglionico, Maria Novella, additional, Fea, Antonio, additional, and Figus, Michele, additional

Published
2023
Full Text
View/download PDF

8. Validation of an Automated Artificial Intelligence Algorithm for the Quantification of Major OCT Parameters in Diabetic Macular Edema

Author

Midena, Edoardo, primary, Toto, Lisa, additional, Frizziero, Luisa, additional, Covello, Giuseppe, additional, Torresin, Tommaso, additional, Midena, Giulia, additional, Danieli, Luca, additional, Pilotto, Elisabetta, additional, Figus, Michele, additional, Mariotti, Cesare, additional, and Lupidi, Marco, additional

Published
2023
Full Text
View/download PDF

10. Italian Candidates for the XEN Implant: An Overview from the Glaucoma Treatment Registry (XEN-GTR)

Author

Posarelli, Chiara, primary, Figus, Michele, additional, Roberti, Gloria, additional, Giammaria, Sara, additional, Ghirelli, Giorgio, additional, Quercioli, Pierpaolo, additional, Micelli Ferrari, Tommaso, additional, Pace, Vincenzo, additional, Mastropasqua, Leonardo, additional, Agnifili, Luca, additional, Sacchi, Matteo, additional, Scuderi, Gianluca, additional, Perdicchi, Andrea, additional, Altafini, Romeo, additional, Uva, Maurizio, additional, D’Andrea, Dino, additional, Covello, Giuseppe, additional, Maglionico, Maria Novella, additional, Fea, Antonio Maria, additional, Carnevale, Carmela, additional, and Oddone, Francesco, additional

Published
2022
Full Text
View/download PDF

14. Behçet's syndrome and ocular involvement: changes over time

Author

Posarelli, Chiara, Maglionico, Maria Novella, Talarico, Rosaria, Covello, Giuseppe, and Figus, Michele

Subjects
Behcet Syndrome, Humans
Abstract

Ocular involvement in Behçet's syndrome still represents a challenge for both rheumatologists and ophthalmologists; over the past 20 years the availability of new diagnostic tools and the concomitant introduction of biologic drugs led to a significant improvement in the management of these patients. The lack of uniform definitions and the diversity of the outcome measures still represent an obstacle for the prompt and correct management of ocular manifestations. The aim of the present review is to summarise the current evidences related to correct diagnosis and proper management of patients with Behçet's syndrome and ocular involvement.

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results